Related Experiment Videos
Comparison of enteric-coated aspirin and uncoated aspirin effect on bleeding time
Insights
Uncoated aspirin significantly increases bleeding time compared to enteric-coated aspirin in healthy volunteers. This suggests uncoated aspirin may be more effective for acute cardiovascular conditions requiring rapid platelet inhibition.
Area of Science:
- Cardiovascular Medicine
- Pharmacology
- Clinical Research
Background:
- Aspirin is crucial for managing acute myocardial infarction (MI), unstable angina, and post-coronary procedures.
- The formulation of aspirin (enteric-coated vs. uncoated) may impact its acute antiplatelet efficacy.
Purpose of the Study:
- To compare the bleeding times in healthy volunteers after ingesting either enteric-coated or uncoated aspirin.
- To determine if differences in bleeding time are clinically significant.
Main Methods:
- A study involving 20 healthy volunteers divided into two groups.
- Administration of either enteric-coated or uncoated aspirin.
- Measurement of bleeding times 4 hours post-ingestion, with <= 8 minutes defined as normal.
Main Results:
- 80% of volunteers taking uncoated aspirin had abnormal bleeding times.
- Only 10% of volunteers taking enteric-coated aspirin had abnormal bleeding times (P < 0.01).
- A significant difference in bleeding times was observed between the two aspirin formulations.
Conclusions:
- Enteric-coated aspirin may be less effective than uncoated aspirin in acutely reducing platelet aggregation.
- Uncoated aspirin is recommended for acute settings like myocardial infarction, unstable angina, or after percutaneous coronary interventions.
Abstract:
Aspirin therapy is an essential part of the drug regimen for patients with acute myocardial infarction (MI), unstable angina, or after coronary angioplasty and coronary stenting. Recognizing this importance, this study sought to compare the bleeding time in two groups of 10 normal volunteers 4 hr after ingestion of either an enteric-coated aspirin or an uncoated aspirin, assuming that a difference between the two groups could be clinically significant. Defining < or = 8 min as normal, 80% of the uncoated group developed abnormal bleeding times, compared to 10% of the enteric-coated group (P < 0.01). The study demonstrates a significant difference between the two types of aspirin preparations on bleeding times in normal individuals. This strongly suggests that some enteric-coated aspirin preparations may not be as effective as uncoated aspirin in acutely decreasing platelet aggregation. Therefore, uncoated aspirin is recommended in the setting of acute MI, unstable angina, or after percutaneous transluminal coronary angioplasty.